JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labrecque, G.
Right arrow Articles by Domino, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labrecque, G.
Right arrow Articles by Domino, E. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 191, Issue 1, 189-200, 1974
Copyright © 1974 by American Society for Pharmacology and Experimental Therapeutics

TOLERANCE TO AND PHYSICAL DEPENDENCE ON MORPHINE: RELATION TO NEOCORTICAL ACETYLCHOLINE RELEASE IN THE CAT

Gaston Labrecque 1 and Edward F. Domino 1

1 Department of Pharmacology, The University of Michigan, Ann Arbor, Michigan

The development of morphine tolerance and naloxone-precipitated withdrawal was studied in intact cats and correlated with neocortical acetylcholine (ACh) release in midpontine pretrigeminal transected preparations. Cats were given morphine sulfate s.c. every 8 hours for 15 days. The dosage (calculated as base) was increased gradually from 9 to 30 mg/kg/day. On gross behavioral observation surviving cats showed obvious tolerance to morphine toward the end of the treatment period. Naloxone, 1.0 mg/kg i.v., induced a withdrawal syndrome characterized by predominant central nervous system depression, vomiting and stupor in five intact cats. The remaining animals were subjected to a midpontine pretrigeminal brainstem transection under halothane-air anesthesia. Subsequently, the neocortical release of ACh after i.v. morphine and/or naloxone was determined. Morphine-tolerant animals had a shift to the right in their dose-effect curves on arterial blood pressure and on inhibition of neocortical ACh release. Similarly electroencephalogram activation produced by acute morphine was less prolonged in the 15-day morphine-treated animals. Naloxone, 1.0 mg/kg i.v., produced an initial hypertension and electroencephalogram slow waves in the morphine-dependent cats. An initial inhibition of ACh release and a subsequent return to control ACh release levels with a possible enhanced release was observed. The data indicate a far more complex diphasic effect on neocortical ACh release during naloxone-precipitated withdrawal than was initially predicted.

Submitted on December 12, 1973
Accepted on May 30, 1974




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. D. Napier, A. Stanfill, D. A. Yoshishige, K. E. Jackson, B. A. Barron, and J. L. Caffrey
Autonomic control of heart rate in dogs treated chronically with morphine
Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2199 - H2210.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics.